People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Software / Tech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sharps Technology Inc. | — | Software / Tech | Growth/Late | $417.3M | $4.4B | 2018 |
| Adult Stem Cell Corp of America | — | Biotechnology | Pre-Seed | $500K | $667K | — |
David Loewenstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Loewenstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| George Cagna | 1 | 3 |
| Paul K. Danner | 1 | 2 |
| Jason L. Monroe | 1 | 1 |
| Soren R. Bo Christiansen | 1 | 1 |
| Timothy J. Ruemler | 1 | 1 |
| Tony Mulone | 1 | 1 |
| Soren Christiansen | 1 | 1 |
| Barry Berler | 1 | 1 |
| Alan Blackman | 1 | 1 |
| Edgar Nouss | 1 | 1 |
| Andrew R. Crescenzo | 1 | 1 |
| Steven Bayern | 1 | 1 |
| Yuwen (Alice) L. Zhang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.